Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Harvard Business School

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018651

« Back to Dashboard

NDA 018651 describes MARINOL, which is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers. Additional details are available on the MARINOL profile page.

The generic ingredient in MARINOL is dronabinol. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dronabinol profile page.

Summary for 018651

Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details

Pharmacology for NDA: 018651


Medical Subject Heading (MeSH) Categories for 018651

Suppliers and Packaging for NDA: 018651

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MARINOL dronabinol CAPSULE;ORAL 018651 NDA AbbVie Inc. 0051-0021 0051-0021-21 1 BOTTLE in 1 CARTON (0051-0021-21) > 60 CAPSULE in 1 BOTTLE
MARINOL dronabinol CAPSULE;ORAL 018651 NDA AbbVie Inc. 0051-0022 0051-0022-21 1 BOTTLE in 1 CARTON (0051-0022-21) > 60 CAPSULE in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength2.5MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 018651

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AbbvieMARINOLdronabinolCAPSULE;ORAL018651-001May 31, 1985► Subscribe► Subscribe
AbbvieMARINOLdronabinolCAPSULE;ORAL018651-003May 31, 1985► Subscribe► Subscribe
AbbvieMARINOLdronabinolCAPSULE;ORAL018651-002May 31, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Johnson and Johnson
US Army
Federal Trade Commission
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: